Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose Antonio Herrero

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nefrologia|March 12, 2023
Nonvalvular atrial fibrillation in patients undergoing chronic hemodialysis. Should dialysis patients with atrial fibrillation receive oral anticoagulation?Carmen Sánchez-González, Jose Antonio Herrero Calvo
Scandinavian Journal of Urology and Nephrology|December 17, 2008
Early initiation of peritoneal dialysis in diabetic patientsFrancisco Coronel, Secundino Cigarran, Jose Antonio Herrero
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|November 6, 2009
Peritoneal protein losses in diabetic patients starting peritoneal dialysis: is there a relationship with diabetic vascular lesions?Francisco Coronel, Secundino Cigarrán, Jose Antonio Herrero, et al.
Journal of Medical Economics|November 11, 2021
Estimating hospital inpatient cost-savings with sucroferric oxyhydroxide in patients on chronic hemodialysis in five European countries: a cost analysisJose Antonio Herrero, Mario Salomone, Antonio Ramirez de Arellano, et al.
International Journal of Nephrology|September 3, 2013
Bisphenol a in chronic kidney diseaseEmilio González-Parra, Jose Antonio Herrero, Usama Elewa, et al.
Journal of Clinical Medicine|August 28, 2025
Predictive Tool for Tunnelled Central Venous Catheter Dysfunction in HaemodialysisVerónica Gimeno-Hernán, Jose Antonio Herrero Calvo, Juan Vicente Beneit Montesinos, et al.
Medicina Clinica|January 20, 2019
Clinical profile of women diagnosed with Fabry disease non receiving enzyme replacement therapyMiguel Ángel Barba-Romero, Joaquin Serena, Josep Maria Puig, et al.
POCUS Journal|December 1, 2025
Peritoneal Volume Influence on POCUS Volume Assessment in Patients Undergoing Peritoneal DialysisMaría Muñiz Rincón, Diego Barbieri, Virginia López de la Manzanara, et al.
Kidney International Reports|December 22, 2025
Randomized Trial of Twice-Weekly Versus Thrice-Weekly Hemodiafiltration for Initiation of Renal Replacement TherapyMilagros Fernández Lucas, Alfonso Muriel, Nuria Rodríguez Mendiola, et al.
Nefrologia|December 23, 2022
Epidemiology of Fabry disease in patients in hemodialysis in the Madrid communityElena Corchete Prats, Emilio González-Parra, Almudena Vega, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nefrologia|March 12, 2023
Nonvalvular atrial fibrillation in patients undergoing chronic hemodialysis. Should dialysis patients with atrial fibrillation receive oral anticoagulation?Carmen Sánchez-González, Jose Antonio Herrero Calvo
Scandinavian Journal of Urology and Nephrology|December 17, 2008
Early initiation of peritoneal dialysis in diabetic patientsFrancisco Coronel, Secundino Cigarran, Jose Antonio Herrero
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|November 6, 2009
Peritoneal protein losses in diabetic patients starting peritoneal dialysis: is there a relationship with diabetic vascular lesions?Francisco Coronel, Secundino Cigarrán, Jose Antonio Herrero, et al.
Journal of Medical Economics|November 11, 2021
Estimating hospital inpatient cost-savings with sucroferric oxyhydroxide in patients on chronic hemodialysis in five European countries: a cost analysisJose Antonio Herrero, Mario Salomone, Antonio Ramirez de Arellano, et al.
International Journal of Nephrology|September 3, 2013
Bisphenol a in chronic kidney diseaseEmilio González-Parra, Jose Antonio Herrero, Usama Elewa, et al.
Journal of Clinical Medicine|August 28, 2025
Predictive Tool for Tunnelled Central Venous Catheter Dysfunction in HaemodialysisVerónica Gimeno-Hernán, Jose Antonio Herrero Calvo, Juan Vicente Beneit Montesinos, et al.
Medicina Clinica|January 20, 2019
Clinical profile of women diagnosed with Fabry disease non receiving enzyme replacement therapyMiguel Ángel Barba-Romero, Joaquin Serena, Josep Maria Puig, et al.
POCUS Journal|December 1, 2025
Peritoneal Volume Influence on POCUS Volume Assessment in Patients Undergoing Peritoneal DialysisMaría Muñiz Rincón, Diego Barbieri, Virginia López de la Manzanara, et al.
Kidney International Reports|December 22, 2025
Randomized Trial of Twice-Weekly Versus Thrice-Weekly Hemodiafiltration for Initiation of Renal Replacement TherapyMilagros Fernández Lucas, Alfonso Muriel, Nuria Rodríguez Mendiola, et al.
Nefrologia|December 23, 2022
Epidemiology of Fabry disease in patients in hemodialysis in the Madrid communityElena Corchete Prats, Emilio González-Parra, Almudena Vega, et al.
Pageof 2